Inhibition of AP‐1 transcription activator induces myc‐dependent apoptosis in HL60 cells

Journal of Cellular Biochemistry - Tập 91 Số 5 - Trang 973-986 - 2004
Seyeon Park1, Eun‐Ryeong Hahm, Dug‐Keun Lee, Chul‐Hak Yang
1School of Chemistry and Molecular Engineering, Seoul National University, Seoul 151-742, Korea

Tóm tắt

AbstractTranscriptional activation of AP‐1 is intricately involved in cell proliferation and transformation. The natural product, nordihydroguaiaretic acid (NDGA) shows an inhibitory effect on the binding of jun/AP‐1 protein to the AP‐1 site in 12‐O‐tetradecanoylphorbol‐13‐acetate (TPA)‐stimulated HL60 cells. The NDGA inhibits the auto‐regulated de novo synthesis of c‐jun mRNA in TPA‐stimulated HL60 cells. Our data also determine that this compound induces proliferation inhibition and apoptosis in human leukemia HL60 cells. To obtain information on the functional role of the AP‐1 inhibition by NDGA in apoptosis signaling, the effects of pharmacological inhibition of AP‐1 binding on c‐myc, p53, and bax protein level were determined. Our results indicate that treatment of cells with NDGA enhances c‐myc, p53, and bax protein levels. To rule out the possibility that NDGA will induce apoptosis because of the effects on proteins other than AP‐1, we investigated the effect of another AP‐1 inhibitor, SP600125, which is specific to Jun‐N‐terminal kinase. SP600125 decreased not only the phosphorylation level of jun protein but also AP‐1/DNA binding activity. Also, apoptosis was observed to be induced by SP600125, concomitant with the increase in c‐myc, p53, and bax protein level. In addition, apoptosis induced by both AP‐1 inhibitors was accompanied by the activation of a downstream apoptotic cascade such as caspase 9, caspase 3, and poly[ADP‐ribose]polymerase (PARP). When the cells were treated with NDGA or SP600125 in the presence of antisense c‐myc oligonucleotides, apoptosis was not observed and an increase of c‐myc, p53, and bax proteins was not manifested. All these results show that the inhibition of the transcription factor AP‐1 action is related with either the drug‐induced apoptosis or the drug toxicity of the HL60 cells. The apoptosis induced by AP‐1 inhibition may be dependent on c‐myc protein levels suggesting that the c‐myc protein induces apoptosis at a low level of AP‐1 binding activity. Altogether, our findings suggest that the presence of the AP‐1 signal acts as a survival factor that determines the outcome of myc‐induced proliferation or apoptosis. © 2004 Wiley‐Liss, Inc.

Từ khóa


Tài liệu tham khảo

Angel P, 1991, The role of Jun, Fos, and the AP‐1 complex in cell proliferation and transformation, Biochem Biophys Acta, 1072, 129

10.1016/0092-8674(87)90611-8

10.1073/pnas.251194298

10.1006/exer.1997.0452

Cotter TG, 1992, The induction of apoptosis by chemotherapeutic agents occurs in all phases of the cell cycle, Anticancer Res, 12, 773

10.1006/excr.1999.4686

10.1038/371171a0

Dent CL, 1993, Transcription factors

10.1038/373257a0

Gunji H, 1991, Induction of internucleosomal DNA fragmentation in human myeloid leukemia cells by 1‐beta‐d‐arabinofuranosylcytosine, Cancer Res, 51, 741

10.1172/JCI12466

10.1038/328445a0

10.1126/science.8091232

10.1038/sj.onc.1204981

10.1146/annurev.bi.58.070189.004055

10.1002/1097-0142(19940415)73:8<2013::AID-CNCR2820730802>3.0.CO;2-J

Kim YS, 2000, Detection of genetic alterations in the human gastric cancer cell lines by two‐dimensional analysis of genomic DNA, Int J Oncol, 17, 297

Mattei MG, 1990, Chromosomal localization of the three members of the jun proto‐oncogene family in mouse and man, Oncogene, 5, 151

10.1126/science.2667136

10.1016/S0092-8674(00)81874-7

10.1038/348080a0

10.1016/S0304-3835(97)00543-0

10.1016/S0304-3835(99)00413-9

10.1016/S0959-437X(99)00046-5

10.1038/sj.onc.1202727

10.1016/0092-8674(88)90077-3

Schutte J, 1988, Constitutive expression of multiple mRNA forms of the c‐jun oncogene in human lung cancer cell lines, Pro Am Assoc Cancer Res, 1808, 455

10.1073/pnas.86.7.2257

10.1016/S0027-5107(00)00166-4

10.1083/jcb.144.2.281

10.1056/NEJM199811053391901

10.1016/0303-7207(89)90149-4

10.1016/0022-1759(95)00072-I

10.1101/gad.8.23.2817

10.1128/MCB.17.11.6755